BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24987060)

  • 1. Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination.
    Ezponda T; Licht JD
    Clin Cancer Res; 2014 Oct; 20(19):5001-8. PubMed ID: 24987060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.
    Nichol JN; Dupéré-Richer D; Ezponda T; Licht JD; Miller WH
    Adv Cancer Res; 2016; 131():59-95. PubMed ID: 27451124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lesson learned from the H3.3K27M mutation found in pediatric glioma: a new approach to the study of the function of histone modifications in vivo?
    Chan KM; Han J; Fang D; Gan H; Zhang Z
    Cell Cycle; 2013 Aug; 12(16):2546-52. PubMed ID: 23907119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.
    Chan KM; Fang D; Gan H; Hashizume R; Yu C; Schroeder M; Gupta N; Mueller S; James CD; Jenkins R; Sarkaria J; Zhang Z
    Genes Dev; 2013 May; 27(9):985-90. PubMed ID: 23603901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2 methyltransferase and H3K27 methylation in breast cancer.
    Yoo KH; Hennighausen L
    Int J Biol Sci; 2012; 8(1):59-65. PubMed ID: 22211105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).
    McCabe MT; Graves AP; Ganji G; Diaz E; Halsey WS; Jiang Y; Smitheman KN; Ott HM; Pappalardi MB; Allen KE; Chen SB; Della Pietra A; Dul E; Hughes AM; Gilbert SA; Thrall SH; Tummino PJ; Kruger RG; Brandt M; Schwartz B; Creasy CL
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2989-94. PubMed ID: 22323599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
    Zheng Y; He L; Wan Y; Song J
    Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probe the function of histone lysine 36 methylation using histone H3 lysine 36 to methionine mutant transgene in mammalian cells.
    Fang D; Gan H; Wang H; Zhou H; Zhang Z
    Cell Cycle; 2017 Oct; 16(19):1781-1789. PubMed ID: 28129023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
    McCabe MT; Ott HM; Ganji G; Korenchuk S; Thompson C; Van Aller GS; Liu Y; Graves AP; Della Pietra A; Diaz E; LaFrance LV; Mellinger M; Duquenne C; Tian X; Kruger RG; McHugh CF; Brandt M; Miller WH; Dhanak D; Verma SK; Tummino PJ; Creasy CL
    Nature; 2012 Dec; 492(7427):108-12. PubMed ID: 23051747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
    Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
    Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.
    van Haaften G; Dalgliesh GL; Davies H; Chen L; Bignell G; Greenman C; Edkins S; Hardy C; O'Meara S; Teague J; Butler A; Hinton J; Latimer C; Andrews J; Barthorpe S; Beare D; Buck G; Campbell PJ; Cole J; Forbes S; Jia M; Jones D; Kok CY; Leroy C; Lin ML; McBride DJ; Maddison M; Maquire S; McLay K; Menzies A; Mironenko T; Mulderrig L; Mudie L; Pleasance E; Shepherd R; Smith R; Stebbings L; Stephens P; Tang G; Tarpey PS; Turner R; Turrell K; Varian J; West S; Widaa S; Wray P; Collins VP; Ichimura K; Law S; Wong J; Yuen ST; Leung SY; Tonon G; DePinho RA; Tai YT; Anderson KC; Kahnoski RJ; Massie A; Khoo SK; Teh BT; Stratton MR; Futreal PA
    Nat Genet; 2009 May; 41(5):521-3. PubMed ID: 19330029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3K27 methylation: a promiscuous repressive chromatin mark.
    Wiles ET; Selker EU
    Curr Opin Genet Dev; 2017 Apr; 43():31-37. PubMed ID: 27940208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.
    Kim JH; Sharma A; Dhar SS; Lee SH; Gu B; Chan CH; Lin HK; Lee MG
    Cancer Res; 2014 Mar; 74(6):1705-17. PubMed ID: 24491801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation.
    Harutyunyan AS; Chen H; Lu T; Horth C; Nikbakht H; Krug B; Russo C; Bareke E; Marchione DM; Coradin M; Garcia BA; Jabado N; Majewski J
    Cell Rep; 2020 Nov; 33(7):108390. PubMed ID: 33207202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Retinal Development via the Epigenetic Modification of Histone H3.
    Watanabe S; Murakami A
    Adv Exp Med Biol; 2016; 854():635-41. PubMed ID: 26427469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.
    Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ
    Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas.
    Venneti S; Garimella MT; Sullivan LM; Martinez D; Huse JT; Heguy A; Santi M; Thompson CB; Judkins AR
    Brain Pathol; 2013 Sep; 23(5):558-64. PubMed ID: 23414300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes.
    Day CA; Hinchcliffe EH; Robinson JP
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic RAS alters the global and gene-specific histone modification pattern during epithelial-mesenchymal transition in colorectal carcinoma cells.
    Peláez IM; Kalogeropoulou M; Ferraro A; Voulgari A; Pankotai T; Boros I; Pintzas A
    Int J Biochem Cell Biol; 2010 Jun; 42(6):911-20. PubMed ID: 20109579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation.
    Li F; Wu R; Cui X; Zha L; Yu L; Shi H; Xue B
    J Biol Chem; 2016 Feb; 291(9):4523-36. PubMed ID: 26733201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.